主管单位:中华人民共和国
国家卫生健康委员会
主办单位:
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文作者:
单位:100029首都医科大学附属北京安贞医院心脏内科监护室
英文单位:
关键词:冠状动脉粥样硬化性心脏病;高密度脂蛋白胆固醇;冠状动脉病变
英文关键词:
【摘要】目的 探讨高密度脂蛋白胆固醇(HDL-C)对冠状动脉粥样硬化性心脏病(冠心病)及冠状动脉多支病变发病的影响。方法 选取2018年1—6月首都医科大学附属北京安贞医院收治的疑似冠心病患者共943例,其中经冠状动脉造影明确冠心病诊断846例(冠心病组),除外冠心病诊断97例(对照组),冠心病组包括单支病变371例、双支病变273例、三支病变202例。比较冠心病组与对照组以及冠心病不同病变支数患者基线资料、各实验室检测指标和Gensini积分的差异,分析冠心病以及冠状动脉多支病变的相关因素。结果 冠心病组男性比例、吸烟史、糖尿病史和白细胞计数、血肌酐、C反应蛋白、B型脑钠肽水平以及Gensini积分均高于对照组,HDL-C水平低于对照组[(1.05±0.29)mmol/L比(1.16±0.27)mmol/L],差异均有统计学意义(均P<0.05)。Logistic回归分析结果显示,Gensini积分和糖尿病史为冠心病发病的危险因素,HDL-C为冠心病发病的保护因素(比值比=0.276,95%置信区间:0.102~0.749,P=0.012)。双支病变组和三支病变组年龄和Gensini积分均高于单支病变组,HDL-C均低于单支病变组[(1.03±0.25)、(1.02±0.35)mmol/L比(1.07±0.27)mmol/L];三支病变组收缩压和B型脑钠肽高于单支病变组,Gensini积分高于双支病变组,糖尿病史、高血压史和血肌酐水平均高于单支、双支病变组,差异均有统计学意义(均P<0.05)。Logistic回归分析结果显示,年龄、男性、Gensini积分、糖尿病史、高血压史为冠心病患者多支病变的危险因素,HDL-C为冠心病患者多支病变的保护因素(比值比=0.299,95%置信区间:0.118~0.754,P=0.011)。结论 随着HDL-C的增高,发生冠心病及冠状动脉多支病变的风险降低,低HDL-C是冠心病、冠状动脉多支病变的独立危险因素。
【Abstract】Objective To investigate the relation between high density lipoprotein cholesterol(HDL-C) and coronary atherosclerotic heart disease(CHD) with multi-vessel lesions. Methods A total of 943 patients with uncertain diagnosis of CHD admitted to Beijing Anzhen Hospital, Capital Medical University from January to June 2018 were included; 846 patients were diagnosed of CHD by coronary angiography(CHD group); 97 patients without CHD were control group. There were 371 cases of single coronary disease, 273 cases of double-vessel disease and 202 cases of triple-vessel disease. Baseline data, laboratory indices and Gensini score were compared among control group and CHD patients with different numbers of lesions. Related factors of CHD and multi-vessel lesions were analyzed. Results Ratios of male, smoking history, diabetes history, levels of white blood cell count, serum creatinine, C-reactive protein, B-type brain natriuretic peptide and Gensini score in CHD group were higher than those in control group; the level of HDL-C in CHD group was lower than that in control group[(1.05±0.29)mmol/L vs (1.16±0.27)mmol/L] and the differences were statistically significant(all P<0.05). Logistic regression showed that Gensini score and diabetes history were risk factors and HDL-C was a protective factor of CHD(odds ratio=0.276, 95% confidence interval: 0.102-0.749, P=0.012). In double-vessel and triple-vessel disease groups, age and Gensini score were higher than those in single-vessel disease group; HDL-C level was lower than that in single-vessel disease group[(1.03±0.25), (1.02±0.35) mmol/L vs (1.07±0.27) mmol/L](all P<0.05). In triple-vessel disease group, systolic blood pressure and serum B-type brain natriuretic peptide level were higher than those in single-vessel disease group; Gensini score was higher than that in double-vessel disease group; ratios of diabetes history and hypertension history and serum creatinine level were higher than those in single vessel and double-vessel disease groups(all P<0.05). Logistic regression showed that age, male, Gensini score, diabetes history and hypertension history were risk factors of multi-vessel lesions; HDL-C was a protective factor of multi-vessel lesions(odds ratio=0.299, 95% confidence interval: 0.118-0.754, P=0.011). Conclusions Increased HDL-C level suggests low risk of CHD and multi-vessel coronary artery disease. Low HDL-C level is an independent risk factor of CHD and multi-vessel lesions.
copyright
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址: 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。